Evidence map›Paper›PMID 35388832›Full record

ArticleThe Analyst2022

Establishing a quantitative fluorescence assay for the rapid detection of kynurenine in urine.

Kamlesh Patel, Marcos Fernandez-Villamarin, Craig Ward, Janet M Lord, Peter Tino, Paula M Mendes

Open access · hybridAbstract read
In one paragraph

Article in The Analyst, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kamlesh PatelSchool of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. p.m.mendes@bham.ac.uk.
Marcos Fernandez-VillamarinSchool of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. p.m.mendes@bham.ac.uk.
Craig WardSchool of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. p.m.mendes@bham.ac.uk.
Janet M LordInstitute of Inflammation and Ageing, University of Birmingham, Mindelsohn Way, Birmingham B15 2TH, UK.
Peter TinoSchool of Computer Science, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Paula M MendesSchool of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. p.m.mendes@bham.ac.uk.ORCID http://orcid.org/0000-0001-6937-7293
University of Birmingham · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kynurenine metabolite is associated with many diseases and disorders, ranging from diabetes and sepsis to more recently COVID-19. Here we report a fluorescence-based assay for the detection of kynurenine in urine using a specific chemosensor, 3-formyl-4-(ethylthio)-7-(diethylamino)-coumarin. The assay produces a linear response at clinically relevant ranges (1-20 μM), with a limit of detection of 0.7 μM. The average standard addition recoveries of kynurenine in synthetic urine samples are near to 100%, and the relative standard deviation values are less than 8%. The established fluorescence assay for quantitative analysis of kynurenine in urine is facile, sensitive and accurate and holds great potential for low-cost and high-throughput analysis of kynurenine in clinical laboratory settings.

Indexed as

COVID-19KynurenineChromatography, High Pressure LiquidHumansKynurenine

Identifiers

PMID35388832
PMCPMC9063859
OpenAlexW4225426319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.